Cargando…

Analysis of composite endpoints in gene expression studies in oncology

Detalles Bibliográficos
Autores principales:	Marhoon, ZA, Borgan, SM, Zakeri, K, Mell, LK
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306011/ http://dx.doi.org/10.1186/1753-6561-9-S1-A17

Ejemplares similares

Do doctors practice what they preach? The wellbeing and lifestyle habits of primary health care physicians in Bahrain
por: Borgan, SM, et al.
Publicado: (2015)

Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review
por: Green, Garrett, et al.
Publicado: (2016)

Improving phase ii oncology trial using best observed RECIST response as an endpoint by modelling continuous tumour measurements
por: Lin, Chien-Ju, et al.
Publicado: (2015)

The feasibility and validity of a preference-weighted composite endpoint to establish value in geriatric care
por: Hofman, Cynthia, et al.
Publicado: (2014)

CMR endpoints for clinical trials: impact of operator experience on the accuracy of image analysis
por: McAlindon, Elisa, et al.
Publicado: (2012)

Statistical evaluation of surrogate endpoints: a systematic review
por: Ensor, Hannah, et al.
Publicado: (2013)

Gene expression profiles and the TP53 mutation status are powerful prognostic markers of breast cancer
por: Langerød, A, et al.
Publicado: (2005)

First case report of usefulness of 18F-FDG PET/CT in diagnosing typhlitis (an oncological emergency)
por: Khan, ZA, et al.
Publicado: (2015)

Endpoint resuscitation-based prediction model for early mortality of severe sepsis and septic shock
por: Sinto, R, et al.
Publicado: (2014)

The win ratio method: a novel hierarchical endpoint for pneumonia trials in patients on mechanical ventilation
por: Montgomery, A, et al.
Publicado: (2014)

The use of historical priors to improve the efficiency of phase II clinical trials with time-to-event endpoints
por: Jackson, Richard, et al.
Publicado: (2013)

Simulation work in adaptive dose-finding designs to identify dose-intervals that achieve targets in multiple endpoints
por: Howlett, James, et al.
Publicado: (2015)

Independent endpoint event review for the elimination of reporting bias in an open label phase III pharmaceutical trial
por: Hall, Peter, et al.
Publicado: (2015)

Phosphocreatine recovery time constant (PCr) at peak exercise as a potential endpoint for clinical trials in PAD
por: Gonzalez, Jorge A, et al.
Publicado: (2016)

Information-theoretic model averaging: a useful method for modelling exploratory secondary endpoints in clinical trials
por: Lythgoe, Daniel
Publicado: (2013)

Development of a comprehensive new endpoint for the evaluation of new treatments for acute decompensated heart failure: results with levosimendan in the REVIVE 1 study
por: Garratt, C, et al.
Publicado: (2004)

Promoter composition predicts gene classes in microarray expression analyses of breast cancer
por: Nordgard, SH, et al.
Publicado: (2005)

Use of an online e-learning module to standardise the assessment and reporting of a subjective endpoint in a multicentre rct
por: Pinkney, Thomas, et al.
Publicado: (2013)

The extracellular matrix composition and responsiveness to breast carcinoma therapy
por: Pupa, SM, et al.
Publicado: (2005)

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
por: Wang, Duolao, et al.
Publicado: (2011)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Alterations in choroid plexus gene expression in Alzheimer’s disease provide inferences for CSF composition and dynamics
por: Miller, Miles C, et al.
Publicado: (2010)

Attenuated NOX2 expression impairs ROS production during the hypoinflammatory phase of sepsis
por: Kuchler, L, et al.
Publicado: (2012)

NUTRIC score in oncologic patients
por: Patrão, A, et al.
Publicado: (2015)

Acute presentation of oncologic disease
por: De Luca, SE, et al.
Publicado: (2014)

CTPA for clinically suspected pulmonary emboli in oncology patients
por: Brook, RC, et al.
Publicado: (2014)

Reporting oncoimaging in the appropriate oncology setting
por: De Luca, S, et al.
Publicado: (2015)

P19-06. The first hypervariable loop and HIV-1 neutralizing antibodies elicited by gp140 env immunogens
por: Ching, LK, et al.
Publicado: (2009)

Analysis of longitudinal oncology quality of life (QoL) data - are we getting it right?
por: Cocks, Kim, et al.
Publicado: (2013)

CMR validation of fractional changes in annulo-apical angles and TAPSE for rapid assessment of right ventricular systolic function
por: Zakeri, Simon A, et al.
Publicado: (2012)

Oncologic surveillance for subjects with biallelic mismatch repair gene mutations-10 year follow-up in a kindred
por: Durno, Carol A, et al.
Publicado: (2011)

Rare oncological diagnosis presenting as ‘rheumatic fever’
por: Sampath, Sunil, et al.
Publicado: (2014)

Electrocardiographic analysis for telemedicine based on a low-cost software approach
por: Cury, LK Pimenta, et al.
Publicado: (2005)

Use of aromatase inhibitor in a girl with peripheral precocious puberty
por: Lee, CY, et al.
Publicado: (2013)

A girl with short stature and dysmorphism
por: Cheng, SW, et al.
Publicado: (2013)

P02.160. The psychosomatic model for clinical oncology
por: Zhirkov, A, et al.
Publicado: (2012)

The lifestyle habits and wellbeing of physicians in Bahrain: a cross-sectional study
por: Borgan, Saif M, et al.
Publicado: (2015)

Is the single variant form of Plasmodium vivax Duffy binding protein-II (PvDBP-II) adequate for inclusion in a PvDBP-II-based vaccine?
por: Valizadeh, Vahideh, et al.
Publicado: (2014)

Gene expression studies in radiation-sensitive cell lines
por: Aarøe, J, et al.
Publicado: (2005)

Epidemic keratoconjunctivitis outbreak in a closed psychiatry ward
por: Rodriguez-Perez, P, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cc1ki725nn4var2rujoh5cjb7h